When Cybersecurity Becomes a Crime

What happens when cybersecurity flaws in medical devices cross the line into criminal violations?

In this episode, Christian and Trevor unpack the groundbreaking case of Illumina, where cybersecurity misrepresentation led to Department of Justice enforcement. They explore how this signals a shift from technical risks to legal and patient safety consequences, highlighting the dangers of cutting corners in device development. The conversation also outlines practical lessons for manufacturers on integrating secure product development, anticipating FDA deficiencies, and aligning business functions with cybersecurity goals.

Key points:

(00:02) Misrepresenting cybersecurity controls in medical devices can lead to legal prosecution under the DOJ’s civil cyber fraud initiative.

(04:28) Regulatory enforcement is evolving beyond HIPAA into direct patient safety risks.

(06:05) Medical device cybersecurity differs from information privacy laws, especially with potential patient harm.

(08:30) The Illumina case involved a whistleblower, FDA oversight, and DOJ enforcement.

(10:54) Ignoring internal warnings about device vulnerabilities led to legal consequences.

(13:44) Security by design must be integrated early to avoid costly retrofits.

(16:46) Cybersecurity is recognized as a clinical risk tied to patient mortality.

(19:12) Manufacturers are adopting secure product development frameworks earlier in the lifecycle.